Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach. (Q36066182)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Andreas Nerlich

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Cristina M Iancu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Marianne Jochum

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

149-163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

Individualized cancer therapy: molecular approaches to the prediction of tumor response

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Proteases, extracellular matrix, and cancer: a workshop of the path B study section

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Matrix metalloprotease inhibitors: design from structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Roles of matrix metalloproteinases in tumor metastasis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Regulation of matrix metalloproteinases: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Metalloproteinase-2 expression correlates with aggressiveness of cutaneous squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Tissue inhibitors of metalloproteinases: evolution, structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Matrix metalloproteinases and their inhibitors in tumour growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Mapping and characterization of the functional epitopes of tissue inhibitor of metalloproteinases (TIMP)-3 using TIMP-1 as the scaffold: a new frontier in TIMP engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

21 January 2018

Alpha 2-macroglobulin

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

MMPs and TIMPs--an historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the Europea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

A phase I and pharmacological study of the matrix metalloproteinase inhibitor BB-3644 in patients with solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

AP-1 in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Membrane type 1 matrix metalloproteinase regulates cellular invasiveness and survival in cutaneous epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Malolactomycin D, a potent inhibitor of transcription controlled by the Ras responsive element, inhibits Ras-mediated transformation activity with suppression of MMP-1 and MMP-9 in NIH3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Soy intake and cancer risk: a review of the in vitro and in vivo data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Anti‐cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Matrix metalloproteinase inhibition by green tea catechins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

Curcumin exerts multiple suppressive effects on human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.1.149

21 January 2018

Identifiers

DOI

10.1586/14737140.5.1.149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15757447%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference